
pmid: 29933821
Alcohol use disorder is a common, destructive, and undertreated disease. As understanding of alcohol use disorder has evolved, so has our ability to manage patients with pharmacotherapeutic agents in addition to nondrug therapy, including various counseling strategies. Providers now have a myriad of medications, both approved and not approved by the US Food and Drug Administration, to choose from and can personalize care based on treatment goals, comorbidities, drug interactions, and drug availability. This review explores these treatment options and offers the prescriber practical advice regarding when each option may or may not be appropriate for a specific patient.
Narcotic Antagonists, Comorbidity, Off-Label Use, Patient Care Planning, United States, Medication Adherence, Alcoholism, Humans, Anticonvulsants, Drug Therapy, Combination, Nicotinic Agonists, Alcohol Deterrents
Narcotic Antagonists, Comorbidity, Off-Label Use, Patient Care Planning, United States, Medication Adherence, Alcoholism, Humans, Anticonvulsants, Drug Therapy, Combination, Nicotinic Agonists, Alcohol Deterrents
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 9 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
